Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Arbutus Biopharma Cp (ABUS)

5.25 0 (0%)

02-23 16:00

Open:

5.25

Pre. Close:

5.25

High:

5.3

Low:

5.05

Volume:

100,124

Market Cap:

289M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.315 - 5.344

5.344 - 5.368

Low:

4.961 - 5.002

5.002 - 5.035

Close:

5.188 - 5.251

5.251 - 5.301

Technical analysis  (as of: 2018-02-23 4:39:51 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 6.46     One year: 6.95

Support:

Support1: 4.85    Support2: 4.04

Resistance:

Resistance1: 5.53    Resistance2: 5.95

Pivot:

5.35

Moving Averages:

MA(5): 5.38     MA(20): 5.30

MA(100): 5.65     MA(250): 4.49

MACD:

MACD(12,26): 0.05     Signal(12,26,9): 0.07

%K %D:

%K(14,3): 36.36     %D(3): 45.45

RSI:

RSI(14): 47.47

52-Week:

High: 8.25  Low: 2.55  Change(%): 90.9

Average Vol(K):

3-Month: 22164  10-Days 21177

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ABUS has closed above bottom band by 40.5%. Bollinger Bands are 20.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 21 Dec 2017 15:33:45 GMT
Risk-Adjusted Net Present Value For Arbutus Biopharma Corp

Thu, 22 Feb 2018 21:33:45 GMT
Arbutus Biopharma (ABUS) Settles Litigation with Acuitas Therapeutics

Wed, 20 Sep 2017 20:26:15 GMT
Here's Why Arbutus Biopharma Corp. Stock Soared Today

Fri, 04 Aug 2017 21:33:45 GMT
Arbutus Biopharma Corp's (ABUS) CEO Mark Murray on Q2 2017 Results - Earnings ...

Mon, 18 Sep 2017 14:48:45 GMT
Arbutus Biopharma: Updates To Thesis

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

55.55

Shares Float (M)

51.02

% Held by Insiders

% Held by Institutions

Shares Short (K)

774

Shares Short Prior Month (K)

521

Stock Financials

EPS

-1.170

EPS Est. Current Year

-1.390

EPS Est. Next Year

-1.350

EPS Est. Next Quarter

-0.420

Forward EPS

-1.409

Book Value (p.s.)

1.880

PEG Ratio

Profit Margin

Operating Margin

-772.76

Return on Assets (ttm)

-68.7

Return on Equity (ttm)

-88.7

Qtrly Rev. Growth

790.4

Gross Profit (p.s.)

-0.973

Sales Per Share

EBITDA (p.s.)

-5.542

Qtrly Earnings Growth

Operating Cash Flow (M)

-53.12

Levered Free Cash Flow (M)

-28.95

atoplab.com

Valuation

P/E

-4.49

P/E Growth Ratio

P/BV

2.79

P/S

1926749952.00

P/CF

-5.49

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.